$2.70
-0.40-12.9%
Last update: Nov 5, 2:24 PM

The average analyst price target for HeartSciences is $10, 270.4% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $8 to $12. The latest change came on Mar 24, 2026, when Ascendiant Capital lowered its price target on HeartSciences from $9.20 to $8 and kept a Buy rating.
Price Target Range — 5 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months